{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:25:26Z","timestamp":1793874326013,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbagen.2026.130995","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:04:23Z","timestamp":1790147063000},"page":"130995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT\/mTOR\/SREBP1 Axis"],"prefix":"10.1016","volume":"1870","author":[{"given":"QingHua","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130995_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2026.130995_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5152\/tjg.2024.24544","article-title":"Pancreatic Cancer: current concepts, trends, and future directions","volume":"36","author":"Wenzel","year":"2024","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0015","article-title":"Advances in the management of pancreatic cancer","volume":"383","author":"Del Chiaro","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.bbagen.2026.130995_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11110574","article-title":"Gemcitabine combination nanotherapies for pancreatic cancer","volume":"11","author":"Samanta","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130995_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45515","article-title":"Comparative outcomes of first-line chemotherapy for metastatic pancreatic Cancer among the regimens used in Japan: a systematic review and network Meta-analysis","volume":"5","author":"Takumoto","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbagen.2026.130995_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102486","article-title":"Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review","volume":"14","author":"Koltai","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbagen.2026.130995_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384948","article-title":"A review of lactate-lactylation in malignancy: its potential in immunotherapy","volume":"15","author":"Zha","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1284344","article-title":"Histone lactylation regulates cancer progression by reshaping the tumor microenvironment","volume":"14","author":"Qu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13148-024-01682-2","article-title":"Lactylation: the novel histone modification influence on gene expression, protein function, and disease","volume":"16","author":"Hu","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbagen.2026.130995_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111468","article-title":"Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbagen.2026.130995_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2024.100544","article-title":"Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer","volume":"80","author":"Hou","year":"2025","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bbagen.2026.130995_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","article-title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.bbagen.2026.130995_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/CBM-210111","article-title":"Targeting PKM2 promotes chemosensitivity of breast cancer cells in vitro and in vivo","volume":"32","author":"Wang","year":"2021","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.bbagen.2026.130995_bb0070","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1021\/acs.jafc.1c05394","article-title":"Cynaropicrin induces cell cycle arrest and apoptosis by inhibiting PKM2 to cause DNA damage and mitochondrial fission in A549 cells","volume":"69","author":"Ding","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbagen.2026.130995_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3375109","article-title":"Pan-cancer analysis of the oncogenic and prognostic role of PKM2: a potential target for survival and immunotherapy","volume":"2023","author":"Liang","year":"2023","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2026.130995_bb0080","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.2147\/CMAR.S178219","article-title":"Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt\/beta-catenin signaling","volume":"10","author":"Lin","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbagen.2026.130995_bb0085","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/jcp.27129","article-title":"Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT\/mTOR\/SREBP-1c axis","volume":"234","author":"Tao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0090","doi-asserted-by":"crossref","first-page":"i472","DOI":"10.1093\/ecco-jcc\/jjae190.0273","article-title":"P0099 histone H4 lysine 12 lactylation in CD4+ T cells promotes the progression of ulcerative colitis through PKM2\/glycolysis loop and PKM2\/STAT3 signaling pathway","volume":"19","author":"Xu","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbagen.2026.130995_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2015.05.017","article-title":"Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells","volume":"336","author":"Kim","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbagen.2026.130995_bb0100","first-page":"3065","article-title":"Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990\/gemcitabine","volume":"18","author":"Yu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbagen.2026.130995_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101131","article-title":"Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway","volume":"22","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107198","article-title":"D-sodium lactate promotes the activation of NF-kappaB signaling pathway induced by lipopolysaccharide via histone lactylation in bovine mammary epithelial cells","volume":"199","author":"Ma","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bbagen.2026.130995_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1564561","article-title":"Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15010039","article-title":"Comparison of hepatic function and chemotherapy-induced side effects between pegylated liposomal doxorubicin (PLD), topotecan (TOPO), and gemcitabine in platinum-resistant ovarian Cancer (PROC)","volume":"15","author":"Dragomir","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bbagen.2026.130995_bb0125","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: a signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10565-024-09951-9","article-title":"The roles of lactate and the interplay with m(6)a modification in diseases","volume":"40","author":"Tang","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.eng.2024.11.036","article-title":"Cancer ENO2 induces histone Lactylation-mediated M2 macrophage polarization and facilitates metastasis of head and neck squamous cell carcinoma","volume":"48","author":"Wang","year":"2025","journal-title":"Engineering"},{"key":"10.1016\/j.bbagen.2026.130995_bb0140","article-title":"Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling","volume":"611","author":"Du","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2026.130995_bb0145","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.cmet.2023.07.005","article-title":"The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity","volume":"35","author":"Sun","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbagen.2026.130995_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12967-025-06246-3","article-title":"Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbagen.2026.130995_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14740\/gr1796","article-title":"Histone Lactylation-driven ubiquitin-specific protease 34 promotes cisplatin resistance in hepatocellular carcinoma","volume":"18","author":"Fan","year":"2025","journal-title":"Gastroenterology Res."},{"key":"10.1016\/j.bbagen.2026.130995_bb0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41419-025-07431-4","article-title":"Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation","volume":"16","author":"He","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2026.130995_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-025-08130-8","article-title":"Mannose inhibits PKM2 lactylation to induce pyroptosis in bladder cancer and activate antitumor immune responses","volume":"8","author":"Jin","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110816","article-title":"Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting beta-catenin signaling pathway","volume":"387","author":"Yu","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbagen.2026.130995_bb0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11064-023-04023-6","article-title":"Silencing PKM2 attenuates brain injury induced by status epilepticus by inhibiting the AKT\/mTOR pathway and the NLRP3 inflammasome","volume":"49","author":"Cui","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbagen.2026.130995_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14120833","article-title":"MC-LR aggravates liver lipid metabolism disorders in obese mice fed a high-fat diet via PI3K\/AKT\/mTOR\/SREBP1 signaling pathway","volume":"14","author":"Chu","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bbagen.2026.130995_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13046-019-1219-7","article-title":"The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130995_bb0190","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/thno.28992","article-title":"LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR Signaling pathway","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbagen.2026.130995_bb0195","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10565-022-09736-y","article-title":"miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR\/AKT\/PI3K pathway in pancreatic cancer","volume":"39","author":"Guo","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bbagen.2026.130995_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10020-021-00300-8","article-title":"Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K\/AKT\/mTOR signaling","volume":"27","author":"Cui","year":"2021","journal-title":"Mol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:29:35Z","timestamp":1793870975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0304416526000954"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130995","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT\/mTOR\/SREBP1 Axis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130995"}}